Historical Funding


Since 1948, the Arthritis Foundation has funded more than $470 million in science grants and we will  continue to mobilize public and private funding for science that guides and accelerates progress toward the prevention and cure of arthritis. Representing the more than 50 million Americans suffering from arthritis, we bring together scientists, clinicians, policymakers, patient groups, and industry partners around shared science goals and strategies that will result in major benefits for people with arthritis.

Historical Data Since Inception (1948-2013)

Number of Funded Scientists: 2665

Number of Funded Institutions: 247

Number of Training Grants: > 2000

Invested Amount: $472,572,923

In 2013 Alone:

Number of Active Research Grants: 129

Number of Active Training Grants: 95

Number of Currently Funded Institutions: 68

Number of Grant Applications Received: 205

Facts and Figures:

  • 2,665 scientists funded since 1948
  • $472,572,923 invested in arthritis science since 1948
  • 205 research grant applications received in 2013
  • 150 peer reviewers each year
  • 2000 hours volunteered by our peer reviewers each year
  • 10-year partnership with CARRA (Childhood Arthritis & Rheumatology Research Alliance)
  • $3,121,224 supporting juvenile arthritis science through CARRA partnership
  • Partners to achieve our research goals: Foundation for National Institutes of Health (FNIH), OA Research Society International (OARSI), Childhood Arthritis & Rheumatology Research Alliance (CARRA), American Orthopaedic Society for Sports Medicine (AOSSM), AOII Foundation, Orthopedic Research Society (ORS)
  • 137 attendees at the AF’s 2012 Segal North American Osteoarthritis Workshop (SNOW) meeting, representing 8 countries and 35 institutions
  • Using his AF research grant in the early 1980s, Dr. Bill Arend studied the role of IL-1 in RA – work that led to the development of Kineret, one of the biologics used to treat RA today
  • $4.7 Million allocated to arthritis science by the Department of Defense thanks to the AF’s advocacy efforts
  • $600,000 toward FNIH partnership on OA Biomarkers to drive toward a new treatment
  • $100,000 toward the public-private Accelerating Medicines Partnership RA/SLE Program